The hepatitis B rivalry between BMS and Gilead will be continued in the hepatitis C market
The BMS-Gilead competitive composition, continued in the chronic hepatitis B treatment market, will revive even in the chronic hepatitis C treatment market.
Recently, BMS has made aggressive behaviors, such as the strategy to reduce prices, to build its position in the domestic chronic hepatitis...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
